Paperpal Prime Logo

Drug Development Research : Impact Factor & More

eISSN: 1098-2299pISSN: 0272-4391

Key Metrics

CiteScore
5.2
H-Index
65
Impact Factor
< 5
SJR
Q2Drug Discovery
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Development Research

Drug Development Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Development Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development Research

Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
  • 1 Aug 2026
  • Drug development research
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance.
  • 1 Aug 2026
  • Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
  • 1 Aug 2026
  • Drug development research
RETRACTION: Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer.
  • 1 Aug 2026
  • Drug development research
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.
  • 1 Aug 2026
  • Drug development research
The Expanding Role of Indole Scaffolds in Combating Antimicrobial Resistance.
  • 1 Aug 2026
  • Drug development research
Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
  • 1 Aug 2026
  • Drug development research
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance.
  • 1 Aug 2026
  • Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
  • 1 Aug 2026
  • Drug development research
RETRACTION: Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer.
  • 1 Aug 2026
  • Drug development research
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.
  • 1 Aug 2026
  • Drug development research
The Expanding Role of Indole Scaffolds in Combating Antimicrobial Resistance.
  • 1 Aug 2026
  • Drug development research

FAQs on Drug Development Research